Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 2/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | EP300 | Q09472 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24701646 | 0.75 | LDHA (0.44) | RAB9AALDH1A1HTR6SLC6A9KMT2A | |
| SCHEMBL25885284 | 0.75 | RAB9A (0.44) | RAB9AALDH1A1HTR6SLC6A9KMT2A | |
| SCHEMBL24701645 | 0.73 | LDHA (0.46) | RAB9AALDH1A1HTR6SLC6A9KMT2A | |
| SCHEMBL24702024 | 0.73 | LNPEP (0.42) | RAB9AALDH1A1HTR6SLC6A9KMT2A | |
| SCHEMBL22678510 | 0.70 | ALDH1A1 (0.39) | RAB9AALDH1A1HTR6SLC6A9CNR1 | |
| SCHEMBL17748789 | 0.69 | CEL (0.44) | RAB9ACNR1KMT2AMEN1 | |
| SCHEMBL31413167 | 0.69 | CEL (0.44) | RAB9ACNR1KMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL3186144 | 0.69 | JAK2 (0.36) | RAB9AALDH1A1CSF1REP300 | |
| SCHEMBL17748779 | 0.69 | PPM1D (0.40) | RAB9AALDH1A1KMT2AMEN1 | |
| SCHEMBL20809131 | 0.69 | MEN1 (0.45) | RAB9AALDH1A1HTR6KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303605-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303605-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | RAB9A 1240/4885ALDH1A1 161/4885HTR6 4293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.